Rein Therapeutics Inc (RNTX) support and resistance · $80.6M cap
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
This page maps Rein Therapeutics Inc (RNTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
RNTX currently screens at market cap $80.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RNTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RNTX quote page for the session range and the stock page for the full model.
Not investment advice.